Information on the total number of voting rights (denominator)
September 21, 2023 11:55 ET
|
Mithra Pharmaceuticals
Information on the total number of voting rights (denominator) Liege, Belgium, 21 September 2023 – 5:45 pm CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health, today...
Notice of Adjustment of the Conversion Price of Mithra's EUR 125,000,000 Senior Unsecured Convertible Bonds due 2025
September 12, 2023 11:45 ET
|
Mithra Pharmaceuticals
Notice of Adjustment of the Conversion Price of Mithra's EUR 125,000,000 Senior Unsecured Convertible Bonds due 2025 (ISIN: BE6325746855) Liege, Belgium, 12 September 2023 – 5:45 pm CEST – Mithra...
Publication of a Transparency Notification Received from Armistice Capital, LLC
September 12, 2023 11:45 ET
|
Mithra Pharmaceuticals
Publication of a Transparency Notification Received from Armistice Capital, LLC Liege, Belgium, 12 September 2023 – 5:45pm CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s...
Letter to Shareholders and Corporate Update
September 11, 2023 01:30 ET
|
Mithra Pharmaceuticals
Letter to Shareholders and Corporate Update Liege, Belgium, 11 September 2023 – 7:30 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health, (the “Company” or “Mithra”),...
Mithra completes EUR 20 million private placement in equity. Update of total number of voting rights (denominator)
August 28, 2023 11:45 ET
|
Mithra Pharmaceuticals
THIS ANNOUNCEMENT IS NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BE PROHIBITED...
Mithra prices private placement to raise EUR 20 million in equity
August 24, 2023 01:33 ET
|
Mithra Pharmaceuticals
THIS ANNOUNCEMENT IS NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BE PROHIBITED...
Mithra and Gedeon Richter Sign Supply Agreement for Production of API for Estelle® and Donesta®
August 08, 2023 01:30 ET
|
Mithra Pharmaceuticals
Mithra and Gedeon Richter Sign Supply Agreement for Production of API for Estelle® and Donesta® Gedeon Richter will manufacture and supply Estetrol (E4) for production of Estelle®,...
Mithra Receives EUR 1.25 Million Milestone Payment from Fuji Pharma under Estelle® Licensing Agreement
August 03, 2023 01:30 ET
|
Mithra Pharmaceuticals
Mithra Receives EUR 1.25 Million Milestone Payment from Fuji Pharma under Estelle® Licensing Agreement Relates to completion of the interim clinical study reports of Phase 3 trials in patients...
Mithra and Searchlight Pharma Announce Donesta® Licensing Agreement for Canada
July 31, 2023 01:30 ET
|
Mithra Pharmaceuticals
Mithra and Searchlight Pharma Announce Donesta® Licensing Agreement for Canada Mithra to receive up to €17.05 million in licensing fees and regulatory and sales milestones, along with tiered...
Mithra and Searchlight Pharma Announce Donesta® Licensing Agreement for Canada
July 31, 2023 01:30 ET
|
Mithra Pharmaceuticals
Mithra and Searchlight Pharma Announce Donesta® Licensing Agreement for Canada Mithra to receive up to €17.05 million in licensing fees and regulatory and sales milestones, along with tiered...